media

Markets

Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Bafna Pharmaceuticals Ltd.
ParticularsMar 20Mar 19Mar 18Mar 17Mar 16
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-15.52-11.48-7.15-10.43-8.80
Diluted EPS (Rs.)-15.52-11.48-7.15-10.43-8.80
Cash EPS (Rs.)-89.52-6.29-5.47-8.17-5.51
Book Value[Excl.RevalReserv]/Share (Rs.)-17.597.9715.7322.5730.95
Book Value[Incl.RevalReserv]/Share (Rs.)-17.597.9715.7322.5730.95
Revenue From Operations / Share (Rs.)179.5418.3319.9434.8245.73
PBDIT / Share (Rs.)6.25-5.36-1.61-2.501.34
PBIT / Share (Rs.)-7.56-6.83-3.29-4.76-1.27
PBT / Share (Rs.)-103.32-7.30-6.22-10.91-8.21
Net Profit / Share (Rs.)-103.32-7.76-7.15-10.43-8.12
NP After MI And SOA / Share (Rs.)-104.54-7.98-7.07-10.23-7.52
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)3.48-29.26-8.05-7.182.92
PBIT Margin (%)-4.20-37.28-16.47-13.68-2.76
PBT Margin (%)-57.54-39.86-31.19-31.34-17.95
Net Profit Margin (%)-57.54-42.32-35.84-29.95-17.74
NP After MI And SOA Margin (%)-58.22-43.52-35.48-29.38-16.44
Return on Networth / Equity (%)0.00-99.01-44.12-44.73-24.28
Return on Capital Employeed (%)-3.29-33.22-9.90-9.17-2.41
Return On Assets (%)-34.67-15.79-12.09-10.70-7.27
Long Term Debt / Equity (X)-0.711.210.610.910.60
Total Debt / Equity (X)-0.712.431.231.931.39
Asset Turnover Ratio (%)0.440.330.300.360.44
      
LIQUIDITY RATIOS     
      
Current Ratio (X)2.110.680.810.941.29
Quick Ratio (X)1.440.550.630.741.11
Inventory Turnover Ratio (X)2.242.661.550.890.97
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)15.48-5.97-0.54-0.400.19
Interest Coverage Ratio (Post Tax) (%)-18.72-8.10-1.44-0.69-0.16
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)-3.2969.21109.10134.30133.55
EV / Net Operating Revenue (X)-0.071.602.312.071.57
EV / EBITDA (X)-2.22-5.45-28.71-28.7653.52
MarketCap / Net Operating Revenue (X)0.040.591.400.840.65
Price / BV (X)-0.491.361.751.290.96
Price / Net Operating Revenue (X)0.040.591.400.840.65
EarningsYield-11.80-0.72-0.25-0.34-0.25
ParticularsMar 20
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)-15.52
Diluted EPS (Rs.)-15.52
Cash EPS (Rs.)-89.52
Book Value[Excl.RevalReserv]/Share (Rs.)-17.59
Book Value[Incl.RevalReserv]/Share (Rs.)-17.59
Revenue From Operations / Share (Rs.)179.54
PBDIT / Share (Rs.)6.25
PBIT / Share (Rs.)-7.56
PBT / Share (Rs.)-103.32
Net Profit / Share (Rs.)-103.32
NP After MI And SOA / Share (Rs.)-104.54
PROFITABILITY RATIOS 
PBDIT Margin (%)3.48
PBIT Margin (%)-4.20
PBT Margin (%)-57.54
Net Profit Margin (%)-57.54
NP After MI And SOA Margin (%)-58.22
Return on Networth / Equity (%)0.00
Return on Capital Employeed (%)-3.29
Return On Assets (%)-34.67
Long Term Debt / Equity (X)-0.71
Total Debt / Equity (X)-0.71
Asset Turnover Ratio (%)0.44
LIQUIDITY RATIOS 
Current Ratio (X)2.11
Quick Ratio (X)1.44
Inventory Turnover Ratio (X)2.24
COVERAGE RATIOS 
Interest Coverage Ratio (%)15.48
Interest Coverage Ratio (Post Tax) (%)-18.72
VALUATION RATIOS 
Enterprise Value (Cr.)-3.29
EV / Net Operating Revenue (X)-0.07
EV / EBITDA (X)-2.22
MarketCap / Net Operating Revenue (X)0.04
Price / BV (X)-0.49
Price / Net Operating Revenue (X)0.04
EarningsYield-11.80